Webinar Replay: The Case for a COVID-19 EBITDA Adjustment

The Case for a COVID-19 EBITDA Adjustment

The Case for a COVID-19 EBITDA Adjustment

In this timely webinar, John Wagner, managing director of 1st West M&A, makes the case for how to treat reduced (or outright lost) EBITDA caused by the COVID-19 pandemic when negotiating a company’s value.

The pandemic is temporary, and should not reduce a company’s long-term valuation. John explains how companies who are selling or recapitalizing their business should demand a “COVID-19 EBITDA adjustment” when negotiating their company’s value.

- Sponsor -

Some points of discussion:

  • EBITDA lost to the pandemic should not be fully averaged into your annual EBITDA
  • COVID-19 will negatively affect you
  • Stick to Your Guns…

Stay Updated

Get our email newsletter with LBM industry trends, data, new products, and best practices.